FINAL REFERRAL and PANEL DISCUSSION

Monday, March 10, 2025

4:50 PM - 5:20 PM ET

Chair(s)

Steven R. Bailey, MD, MSCAI

Professor of Medicine
LSU Health Shreveport
San Antonio, Texas, United States

No relationships to disclose

Co-Chair(s)

Israel Barbash, MD

Interventional Cardiologist
Leviev Heart Center, Sheba Medical Center
Shoham, HaMerkaz, Israel

No relationships to disclose

Judge(s)

Yuval Binur, PhD

Managing Partner
Arsuf Global Partners
NEW YORK, New York, United States

No relationships to disclose
Sam Chitsaz, MD FACC FSCAI

Interventional Cardiologist
Sutter Health

No relationships to disclose
Tim A. Fischell, MD, FACC

Director of Cardiovascular Research
Ascension Borgess Heart Institute
Kalamazoo, Michigan, United States

Disclosure information not submitted.
Nicolas Foin, MSc, PhD

Founder/ Adj Associate Professor
Dhenin/ Duke-NUS Medical School
Brussels, Brussels Hoofdstedelijk Gewest, Belgium

No relationships to disclose
Chaim Shaul Lotan, MD

Chief Innovation Officer
Hadassah-Hebrew University Medical Center
Jerusalem, Israel

No relationships to disclose
Jonathan Schwartz, MD

Enterprise Director of Cardiovascular Innovation, Structural Interventional Cardiologist
Sanger Heart & Vascular Institute, North Carolina, United States

No relationships to disclose
Mark A. Turco, MD

CEO & President
JC Medical and Genesis MedTech
Providence, Rhode Island, United States

No relationships to disclose
Valavanur A. Subramanian, MD

Founder and Director Of Board
HRT- Heart Repair Technologies Inc.
New York, New York, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Steven R. Bailey, MD, MSCAI: No financial relationships to disclose

Israel Barbash, MD: No financial relationships to disclose

Yuval Binur, PhD: No financial relationships to disclose

Sam Chitsaz, MD FACC FSCAI: No financial relationships to disclose

Tim A. Fischell, MD, FACC: Ablative Solutions, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing); Cordis, Endovascular Division: Royalties (Ongoing); Vantis Vascular, Inc.: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing)

Nicolas Foin, MSc, PhD: CoreAalst: Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Medinbox: Consultant (Ongoing), Exec. Board, Mandate (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Chaim Shaul Lotan, MD: No financial relationships to disclose

Jonathan Schwartz, MD: Abbott Vascular: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Cordis: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); CorFlow Therapeutics: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Lifelens LLC: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Medtronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Philips: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); RapidAI: Consultant (Ongoing); Siemens: Consultant (Ongoing); W.L. Gore & Associates: Consultant (Ongoing)

Mark A. Turco, MD: No financial relationships to disclose

Valavanur A. Subramanian, MD: No financial relationships to disclose